ARONORA INC
Last verified 2026-05-05. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.8Mattributed |
|---|---|
| Latest round | grant, $2.8M, 2024-07-01attributed |
| Founded | 2008 |
| Headquarters | PORTLAND, Oregon, USA |
| Industry | bio |
| Stage | unknown |
| Website | aronorabio.com |
Clinical-stage biotech developing antithrombotic biologics including AB023 and rZPI for thrombosis without bleeding-risk side effects. Targets pharma partners and patients needing safer anticoagulation in surgery, dialysis, and post-stroke care. Differentiates by targeting contact pathway proteins so patients get clot prevention without classical bleeding risk.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-07-01 | grant | $2.8M | undisclosed |
Detected tech stack
Cloudflare, WordPress, Yoast SEO 27.5, reCAPTCHA, Google Analytics, Google Tag Manager, jQuery Migrate, PHP, DoubleClick Floodlight, Cloudflare Bot Management, WP Engine, WP Rocket 3.21.2
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.8M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $2.8M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | aronorabio.com, read 2026-05-05 |
| Description | self-reported | aronorabio.com, read 2026-05-05 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.